Humalog Mix75/25 is a prescription drug approved by the Food and Drug Administration (FDA) to treat diabetes. Humalog Mix75/25 is also referred to by its drug name, 75% insulin lispro protamine and 25% insulin lispro (rDNA origin).
Humalog Mix75/25 is a combination of rapid-acting and intermediate-acting human insulin analogs. An insulin analog is a synthetic substance very similar to human insulin. Insulin analogs are designed to affect the body more predictably than human insulin does.
How do I take it?
Prescribing information states that Humalog Mix75/25 should be administered via a subcutaneous injection. Your doctor will explain when and where you should inject Humalog Mix75/25 and how to measure your dosage.
Humalog Mix75/25 comes as a liquid in vials and prefilled pens.
The FDA-approved label for Humalog Mix75/25 lists common side effects including hypoglycemia (low blood glucose), swelling of the extremities, lipodystrophy (fat degeneration), and minor redness or irritation at injection sites.
Rare but serious side effects listed for Humalog Mix75/25 can include a systemic allergic reaction and heart failure.